Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia

<div>Patients treated with drugs initially proposed for the management of COVID-19 and that are associated with risk of QT interval prolongation in 21 hospital institutions, Colombia, 2019–2020.</div>

International Journal of Vascular Medicine

fig2

Figure 2

Figure 2: Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia 